{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T12:17:53Z","timestamp":1777897073878,"version":"3.51.4"},"reference-count":49,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Substance Abuse"],"published-print":{"date-parts":[[2016,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Methadone and buprenorphine have been demonstrated to be effective in the treatment of opioid use disorder (OUD), especially when combined with psychosocial treatment. Despite buprenorphine's association with fewer withdrawal symptoms and lessened risk of abuse, compared with methadone, its adoption remains limited. Given the vital role that counselors may play in its successful implementation, their knowledge and perceptions of opioid agonist therapy may be facilitators or barriers to its acceptance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Informed by diffusion theory, the current study examined perceptions of buprenorphine's and methadone's acceptability among 725 counselors employed in a nationally representative sample of substance use disorder treatment centers. First, we provided descriptive statistics about medication diffusion, extent of training received about the medications, and perceptions of acceptability of each medication. Then, we compared acceptability of opioid agonists with other treatment approaches for OUD. Finally, we conducted 2 ordinary least squares regressions to examine counselor acceptability of buprenorphine and of methadone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Descriptive statistics suggested that diffusion of information about buprenorphine and methadone was not complete, and training was not extensive for either medication. Counselors reported greater acceptability and training of buprenorphine compared with methadone. Methadone was rated as the least acceptable among all other treatment approaches. Multivariate analyses indicated regional differences, and that medication-specific training, adaptability, and educational attainment were positively related with perceptions of acceptability of either medication, even after controlling for organizational characteristics. Adherence to a 12-step orientation was negatively associated with acceptability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Dissemination of information about opioid agonist therapy is occurring. Nevertheless, the fact that 20% of counselors admitted not knowing enough about either buprenorphine's or methadone's effectiveness is surprising in light of the extensive literature documenting their effectiveness. Future research should focus upon different types of training that can inform physicians, counselors, and patients about the use of opioid agonist therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1080\/08897077.2015.1062457","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T20:38:10Z","timestamp":1436819890000},"page":"47-53","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":39,"title":["Counselor Training and Attitudes toward Pharmacotherapies for Opioid Use Disorder"],"prefix":"10.1177","volume":"37","author":[{"given":"Lydia","family":"Aletraris","sequence":"first","affiliation":[{"name":"Owens Institute for Behavioral Research, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Bond","family":"Edmond","sequence":"additional","affiliation":[{"name":"Owens Institute for Behavioral Research, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Paino","sequence":"additional","affiliation":[{"name":"Department of Sociology, Anthropology, Social Work, and Criminal Justice, Oakland University, Rochester, Michigan, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dail","family":"Fields","sequence":"additional","affiliation":[{"name":"Owens Institute for Behavioral Research, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul M.","family":"Roman","sequence":"additional","affiliation":[{"name":"Owens Institute for Behavioral Research, University of Georgia, Athens, Georgia, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"e_1_3_3_2_2","volume-title":"Heroin and Other Opiate Admissions to Substance Abuse Treatment: The TEDS Report","author":"Substance Abuse and Mental Health Services Administration","year":"2009","unstructured":"Substance Abuse and Mental Health Services Administration. Heroin and Other Opiate Admissions to Substance Abuse Treatment: The TEDS Report. Rockville, MD: US Department of Health and Human Services; 2009."},{"key":"e_1_3_3_3_2","volume-title":"Results from the 2008 National Survey on Drug Use and Health: National Findings","author":"Substance Abuse and Mental Health Services Administration (SAMHSA)","year":"2009","unstructured":"Substance Abuse and Mental Health Services Administration (SAMHSA). Results from the 2008 National Survey on Drug Use and Health: National Findings. Office Of Applied Studies, NSDUH series H-36, HHS publication no. SMA 09\u20134434. Rockville, MD: US Department of Health and Human Services; 2009."},{"key":"e_1_3_3_4_2","volume-title":"Treatment Episode Data Set (TEDS): 2001\u20132011. National Admissions to Substance Abuse Treatment Services","author":"Substance Abuse and Mental Health Services Administration","year":"2013","unstructured":"Substance Abuse and Mental Health Services Administration. Treatment Episode Data Set (TEDS): 2001\u20132011. National Admissions to Substance Abuse Treatment Services. BHSIS Series S-65, HHS Publication No. (SMA) 13\u20134772. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013."},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2004.12.008"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2003.11.002"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.2001.9656834.x"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1360-0443.1998.9344753.x"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.1080\/09595230020029419"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490802268835"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa022164"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0376-8716(03)00059-0"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.03.020"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1081\/ADA-120002972"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2005.01154.x"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490490440807"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1497.2005.0228.x"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2008.12.004"},{"key":"e_1_3_3_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3181b41a32"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.09.002"},{"key":"e_1_3_3_21_2","volume-title":"The Diffusion of Innovations","author":"Rogers EM.","year":"2003","unstructured":"Rogers EM. The Diffusion of Innovations. 4th ed. New York: Free Press; 2003.","edition":"4"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0b013e31820a8226"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-7189(02)00092-7"},{"key":"e_1_3_3_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-4-50"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2005.05.002"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2011.05.005"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1080\/10550490701525418"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1300\/J126v03n01_05"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.2307\/259164"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00319-7"},{"key":"e_1_3_3_31_2","volume-title":"Inside Rehab","author":"Fletcher AM.","year":"2013","unstructured":"Fletcher AM. Inside Rehab. New York, NY: Viking; 2013."},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-7358(03)00053-9"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.15288\/jsad.2009.70.628"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00233-7"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(02)00231-3"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.2307\/2393553"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2006.12.026"},{"key":"e_1_3_3_38_2","volume-title":"The NSDUH Report: State Estimates of Nonmedical Use of Prescription Pain Relievers","author":"Substance Abuse and Mental Health Services Administration","year":"2013","unstructured":"Substance Abuse and Mental Health Services Administration. The NSDUH Report: State Estimates of Nonmedical Use of Prescription Pain Relievers. Rockville, MD: Center for Behavioral Health Statistics and Quality; 2013."},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.3109\/10826088509047261"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1093\/jurban\/79.4.571"},{"key":"e_1_3_3_41_2","volume-title":"Patient Placement Criteria for the Treatment of Substance Related Disorders","author":"Mee-Lee DL","year":"1996","unstructured":"Mee-Lee DL, , Gartner L, , Miller MM, , Shulman GD, , Wilford BB. Patient Placement Criteria for the Treatment of Substance Related Disorders. 2nd ed. Chevy Chase, MD: American Society of Addiction Medicine; 1996.","edition":"2"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1081\/JA-100102626"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2012.10.004"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0740-5472(01)00173-8"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1037\/a0022284"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2010.01128.x"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1093\/poq\/nfn011"},{"key":"e_1_3_3_48_2","volume-title":"National Survey of Substance Abuse Treatment Services (N-SSATS): 2012. Data on Substance Abuse Treatment Facilities","author":"Substance Abuse and Mental Health Services Administration","year":"2013","unstructured":"Substance Abuse and Mental Health Services Administration. National Survey of Substance Abuse Treatment Services (N-SSATS): 2012. Data on Substance Abuse Treatment Facilities. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013."},{"key":"e_1_3_3_49_2","first-page":"24","article-title":"Trends in the use of buprenorphine by office-based physicians in the United States, 2003\u20132013","volume":"24","author":"Turner L, Kruszewski SP, Alexander FC","year":"2015","unstructured":"Turner L, Kruszewski SP, Alexander FC. Trends in the use of buprenorphine by office-based physicians in the United States, 2003\u20132013. Am J Addict. 2015;24:24\u201329.","journal-title":"Am J Addict"},{"key":"e_1_3_3_50_2","volume-title":"Healthcare Reform Impact at a Glance: What's in It for Persons With Mental and Addiction Disorders","author":"National Association of Community Health Centers","year":"2010","unstructured":"National Association of Community Health Centers. Healthcare Reform Impact at a Glance: What's in It for Persons With Mental and Addiction Disorders. Washington, DC: National Council for Community Behavioral Healthcare; 2010."}],"container-title":["Substance Abuse"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2015.1062457","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1080\/08897077.2015.1062457","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/08897077.2015.1062457","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T08:46:24Z","timestamp":1777625184000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/08897077.2015.1062457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["10.1080\/08897077.2015.1062457"],"URL":"https:\/\/doi.org\/10.1080\/08897077.2015.1062457","relation":{},"ISSN":["0889-7077","1547-0164"],"issn-type":[{"value":"0889-7077","type":"print"},{"value":"1547-0164","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1]]}}}